Announced details
Determination of the efficacy and sensitivity of antibodies that suppress the proliferation of cancer cells
Joint research with Nagoya University. The patent holders are the National University Corporation Tokai National Higher Education and Research System and Perseus Proteomics Inc.
Location: Furo-cho, Chikusa-ku, Nagoya, Aichi Prefecture. A university belonging to the National University Corporation Tokai National Higher Education and Research System. Other details: Not disclosed
Patent No. 7875530; registration date: 10 June 2026. Expiration date: Not disclosed
There is no impact on the earnings forecast for the current fiscal year. The research is expected to contribute to an increase in corporate value over the medium to long term through future business development and other initiatives.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Method for determining the efficacy or sensitivity of anti-transferrin receptor antibodies |
| Counterparty | Nagoya University, National University Corporation Tokai National Higher Education and Research System |
| Counterparty overview | Location: Furo-cho, Chikusa-ku, Nagoya, Aichi Prefecture. A university belonging to the National University Corporation Tokai National Higher Education and Research System. Other details: Not disclosed |
| Relationship with the Company | Joint research with Nagoya University. The patent holders are the National University Corporation Tokai National Higher Education and Research System and Perseus Proteomics Inc. |
| Applicable area | Determination of the efficacy and sensitivity of antibodies that suppress the proliferation of cancer cells |
| Registration number and expiry date | Patent No. 7875530; registration date: 10 June 2026. Expiration date: Not disclosed |
| Impact on Business Performance | There is no impact on the earnings forecast for the current fiscal year. The research is expected to contribute to an increase in corporate value over the medium to long term through future business development and other initiatives. |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The research group at Nagoya University and the Company analyzed the mechanism by which anti-transferrin receptor antibodies suppress the proliferation of cancer cells, and obtained intellectual property rights for the results.